Company Registration No. 13072839 (England and Wales)
Calita Nutraceuticals Ltd
Unaudited accounts
for the year ended 31 December 2022
Calita Nutraceuticals Ltd
Unaudited accounts
Contents
Calita Nutraceuticals Ltd
Statement of financial position
as at 31 December 2022
Tangible assets
228,528
251,638
Inventories
275,756
159,211
Cash at bank and in hand
36,656
41,810
Creditors: amounts falling due within one year
(981,261)
(588,919)
Net current liabilities
(548,100)
(363,608)
Total assets less current liabilities
(319,572)
(111,970)
Provisions for liabilities
Deferred tax
(43,420)
(47,811)
Net liabilities
(362,992)
(159,781)
Called up share capital
100
100
Profit and loss account
(363,092)
(159,881)
Shareholders' funds
(362,992)
(159,781)
For the year ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2023 and were signed on its behalf by
Alka Agarwal
Director
Company Registration No. 13072839
Calita Nutraceuticals Ltd
Notes to the Accounts
for the year ended 31 December 2022
Calita Nutraceuticals Ltd is a private company, limited by shares, registered in England and Wales, registration number 13072839. The registered office is Unit 1B, Great Central Industrial Estate, Great Central Way, Rugby, CV21 3XH.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
Over the term of the lease
Plant & machinery
Straight line over 3 years
Fixtures & fittings
Straight line over 3 years
Computer equipment
Straight line over 3 years
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Calita Nutraceuticals Ltd
Notes to the Accounts
for the year ended 31 December 2022
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
4
Tangible fixed assets
Land & buildings
Plant & machinery
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At cost
At 1 January 2022
102,266
178,373
14,506
1,632
296,777
Additions
-
60,306
7,074
-
67,380
At 31 December 2022
102,266
238,679
21,580
1,632
364,157
At 1 January 2022
5,501
36,862
2,570
206
45,139
Charge for the year
10,622
73,625
5,699
544
90,490
At 31 December 2022
16,123
110,487
8,269
750
135,629
At 31 December 2022
86,143
128,192
13,311
882
228,528
At 31 December 2021
96,765
141,511
11,936
1,426
251,638
Amounts falling due within one year
Accrued income and prepayments
9,054
290
Other debtors
24,210
24,000
6
Creditors: amounts falling due within one year
2022
2021
Trade creditors
188,212
77,748
Taxes and social security
8,144
14,638
Other creditors
445,882
162,604
Loans from directors
322,000
315,000
7
Average number of employees
During the year the average number of employees was 26 (2021: 19).